Trials / Completed
CompletedNCT01926288
Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 287 (actual)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Entecavir maleate tablets in Chinese patients with hepatitis B
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Entecavir maleate tablets | |
| DRUG | blank Baraclude tablets | |
| DRUG | Blank maleate entecavir tablets | |
| DRUG | Baraclude tablets |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2013-08-20
- Last updated
- 2017-12-29
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01926288. Inclusion in this directory is not an endorsement.